Dow Down 2.40% Nasdaq Down 1.66%

More On GEN.CO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Genmab A/S (GEN.CO)

-Copenhagen
653.50 Down 20.50(3.04%) 10:59AM EST
Prev Close:674.00
Open:669.00
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:634.50 - 669.00
52wk Range:453.10 - 993.00
Volume:406,122
Avg Vol (3m):384,873
Market Cap:38.90B
P/E (ttm):89.06
EPS (ttm):7.34
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in DKK.

Headlines

» More Headlines for GEN.CO

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):51.65
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-11) :N/A
Quarterly EPS Est (Sep-11) :N/A
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Genmab A/S, a biotechnology company, develops human antibody therapeutics for the treatment of cancer in Denmark, the Netherlands, the United States, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback